Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) EPS (Weighted Average and Diluted): 2019-2024

Historic EPS (Weighted Average and Diluted) for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $2.51.

  • Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) rose 10.13% to $0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.18, marking a year-over-year increase of 50.71%. This contributed to the annual value of $2.51 for FY2024, which is 17.84% up from last year.
  • Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) amounted to $2.51 in FY2024, which was up 17.84% from $2.13 recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) ranged from a high of $2.97 in FY2022 and a low of -$2.48 during FY2020.
  • Its 3-year average for EPS (Weighted Average and Diluted) is $2.54, with a median of $2.51 in 2024.
  • Per our database at Business Quant, Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) soared by 412.07% in 2022 and then fell by 28.28% in 2023.
  • Harmony Biosciences Holdings' EPS (Weighted Average and Diluted) (Yearly) stood at -$2.48 in 2020, then skyrocketed by 123.39% to $0.58 in 2021, then surged by 412.07% to $2.97 in 2022, then declined by 28.28% to $2.13 in 2023, then increased by 17.84% to $2.51 in 2024.